Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

236.99
Delayed Data
As of Aug 30
 +0.34 / +0.14%
Today’s Change
195.50
Today|||52-Week Range
322.68
-24.16%
Year-to-Date
Your Complete Guide to the Generic Drug Industry
Aug 29 / Zacks.com - Paid Partner Content
Cempra's Application for Pneumonia Drug Validated in EU
Aug 24 / Zacks.com - Paid Partner Content
Top Research Reports for Apple, Allergan & Occidental Petroleum
Aug 29 / Zacks.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Allergan: An Undervalued Powerhouse
Aug 28 / GuruFocus News - Paid Partner Content
Which Criteria Best Determine the Success of Mergers?
Aug 24 / GuruFocus News - Paid Partner Content
Hedge Funds Love Liberty and John Malone
Aug 26 / GuruFocus News - Paid Partner Content
5 Things You Must Know Before the Market Opens Wednesday
Aug 24 / TheStreet.com - Paid Partner Content
FTC Details Concerns on Generic Drug Company Mergers
Aug 26 / TheStreet.com - Paid Partner Content
Pfizer Picks Up AstraZeneca's Antibiotics Business
Aug 24 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close236.65
Today’s open235.52
Day’s range235.52 - 238.65
Volume2,461,459
Average volume (3 months)3,458,790
Market cap$93.7B
Dividend yield--
Data as of 4:02pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+4.88%
Earnings growth (next 5 years)+12.80%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.08+0.17%
BMYBristol-Myers Squibb-1.52-2.59%
SNYSanofi-0.15-0.39%
LLYEli Lilly and Co-0.83-1.06%
Data as of 4:02pm ET, 08/30/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$3.64
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs